Income Statement
CRYO CELL INTERNATIONAL INC
CCEL
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Nov 30, 2025 2025 FY | Nov 30, 2024 2024 FY | Nov 30, 2023 2023 FY | Nov 30, 2022 2022 FY | Nov 30, 2021 2021 FY | Nov 30, 2020 2020 FY | Nov 30, 2019 2019 FY | Nov 30, 2018 2018 FY | Nov 30, 2017 2017 FY | Nov 30, 2016 2016 FY | Nov 30, 2015 2015 FY | Nov 30, 2014 2014 FY | Nov 30, 2013 2013 FY | Nov 30, 2012 2012 FY | Nov 30, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - | - | 25.38 | 23.13 | 21.09 | 20.13 | 18.99 | 17.97 | 17.92 |
|
Cost of Revenue
|
7.38 | 7.95 | 8.44 | 8.79 | 8.99 | 9.66 | 10.04 | 8.54 | - | - | - | - | - | - | - |
|
Gross Profit
|
-7.38 | -7.95 | -8.44 | -8.79 | -8.99 | -9.66 | -10.04 | -8.54 | 25.38 | 23.13 | 21.09 | 20.13 | 18.99 | 17.97 | 17.92 |
|
Operating Expenses
|
18.60 | 19.76 | 18.29 | 15.97 | 14.68 | 14.32 | 14.92 | 15.72 | 13.52 | 14.78 | 12.44 | 12.32 | 11.40 | 14.54 | 12.60 |
|
Research & Development
|
0.38 | 1.24 | 1.17 | 0.38 | 0.05 | 0.02 | 0.03 | 0.09 | 0.04 | 0.05 | 0.05 | 0.06 | 0.04 | 0.11 | 0.18 |
|
Selling, General & Administrative
|
18.22 | 18.52 | 17.12 | 15.58 | 14.63 | 14.29 | 14.89 | 15.63 | 13.48 | 14.72 | 12.39 | 12.25 | 11.37 | 14.43 | 12.41 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-25.97 | -27.71 | -26.73 | -24.76 | -23.66 | -23.98 | -24.96 | -24.26 | 11.86 | 8.35 | 8.66 | 7.81 | 7.59 | 3.43 | 5.32 |
|
Non-Operating Income
|
-2.82 | -0.68 | -1.06 | -0.71 | -1.39 | -2.62 | -1.67 | -1.57 | -1.38 | -2.91 | -1.96 | -0.94 | -1.35 | -2.55 | -1.42 |
|
Interest Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - | 0.06 | 0.04 |
|
Interest Expense
|
2.07 | 1.86 | 1.24 | 1.52 | 1.38 | 1.54 | 1.70 | 1.55 | 1.30 | 0.95 | 1.30 | 1.15 | 1.40 | 1.02 | 1.46 |
|
Other Non-Op Income / Expense
|
0.05 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | -0.02 | -0.08 | -0.01 | 0.02 | -0.36 | -0.15 | -0.15 | -0.23 |
|
Income Before Tax
|
-2.34 | 2.80 | -13.36 | 3.32 | 2.61 | 5.04 | 3.39 | 3.62 | 3.62 | -2.48 | 0.97 | 1.04 | 0.35 | -4.27 | -1.70 |
|
Income Tax Expense
|
0.09 | 2.40 | -3.84 | 0.55 | 0.53 | 1.41 | 1.10 | 4.47 | 1.31 | -1.16 | -7.14 | 0.49 | 0.32 | 1.89 | 0.17 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-2.43 | 0.40 | -9.52 | 2.77 | 2.08 | 3.62 | 2.29 | -0.85 | 2.32 | -1.32 | 8.11 | 0.55 | 0.03 | -6.31 | -2.10 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Nov 30, 2025 2025 FY | Nov 30, 2024 2024 FY | Nov 30, 2023 2023 FY | Nov 30, 2022 2022 FY | Nov 30, 2021 2021 FY | Nov 30, 2020 2020 FY | Nov 30, 2019 2019 FY | Nov 30, 2018 2018 FY | Nov 30, 2017 2017 FY | Nov 30, 2016 2016 FY | Nov 30, 2015 2015 FY | Nov 30, 2014 2014 FY | Nov 30, 2013 2013 FY | Nov 30, 2012 2012 FY | Nov 30, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-25.22 | -27.23 | -25.61 | -23.64 | -22.83 | -23.60 | -24.56 | -23.95 | 11.99 | 8.59 | 8.87 | 7.98 | 7.78 | 3.64 | 5.68 |
|
Earnings Per Share (Basic)
|
-0.30 | 0.05 | -1.14 | 0.33 | 0.26 | 0.48 | 0.29 | -0.11 | 0.33 | -0.16 | 0.85 | 0.05 | 0.00 | -0.56 | -0.18 |
|
Diluted EPS
|
-0.30 | 0.05 | -1.14 | 0.33 | 0.25 | 0.45 | 0.27 | -0.11 | 0.30 | -0.16 | 0.83 | 0.05 | 0.00 | -0.56 | -0.18 |
|
Weighted Average Shares
|
8.07 | 8.13 | 8.34 | 8.47 | 8.14 | 7.54 | 7.79 | 7.46 | 7.06 | 8.11 | 9.54 | 10.18 | 10.86 | 11.31 | 11.76 |
|
Diluted Weighted Avg Shares
|
8.07 | 8.21 | 8.34 | 8.48 | 8.36 | 8.14 | 8.41 | 7.46 | 7.65 | 8.11 | 9.80 | 10.43 | 10.97 | 11.31 | 11.76 |
|
Comprehensive Income
|
- | - | - | - | - | - | 2.29 | -0.55 | 2.32 | -1.46 | 8.28 | - | - | - | -2.00 |